Buckle D R, Outred D J, Rockell C J, Smith H, Spicer B A
J Med Chem. 1983 Feb;26(2):251-4. doi: 10.1021/jm00356a025.
A series of the little compounds was prepared by cyclization of the appropriate 5-(aryloxy)-v-triazole-4-carboxylic acids and evaluated for antiallergic activity by the rat passive cutaneous anaphylaxis (PCA) screen. The most potent compounds were 6-(mesyloxy)-9-oxo-1H,9H-benzopyrano[2,3-d]-v-triazole and its 5-methyl homologue, which were some tenfold more potent than disodium cromoglycate. Dialkyl derivatives, especially those substituted at C-5 and C-6 or C-6 and C-7, and 6-methoxy compounds were also among the more potent compounds. One compound, 6,7-dimethyl-9-oxo-1H,9H-benzopyrano[2,3-d]-v-triazole, was further evaluated and shown to be a potent inhibitor of rat PCA when given orally.
通过使适当的5 - (芳氧基) - v - 三唑 - 4 - 羧酸环化制备了一系列小化合物,并通过大鼠被动皮肤过敏反应(PCA)筛选评估其抗过敏活性。最有效的化合物是6 - (甲磺酰氧基) - 9 - 氧代 - 1H,9H - 苯并吡喃并[2,3 - d] - v - 三唑及其5 - 甲基同系物,其效力比色甘酸二钠强约十倍。二烷基衍生物,特别是在C - 5和C - 6或C - 6和C - 7处取代的那些,以及6 - 甲氧基化合物也属于效力较强的化合物。一种化合物,6,7 - 二甲基 - 9 - 氧代 - 1H,9H - 苯并吡喃并[2,3 - d] - v - 三唑,经过进一步评估,结果表明口服时它是大鼠PCA的有效抑制剂。